RAM BIOTECH ApS: Financial statements 2023
CVR: 26923573
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
RAM BIOTECH ApS (CVR 26923573) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -24,547 and a net result of DKK -24,578 compared with DKK -28,654 the year before. Equity in the 2023 report amounted to DKK 283,676. The solvency ratio was 91%.
- Gross Profit
- DKK -24,547
- Profit/Loss
- DKK -24,578
- Equity
- DKK 283,676
- Total Assets
- DKK 311,567
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -25 t. | -25 t. | 284 t. | - |
| 2022 | - | -26 t. | -29 t. | 308 t. | - |
| 2021 | - | 74 t. | 72 t. | 337 t. | - |
| 2020 | - | 47 t. | 47 t. | 265 t. | 0 |
| 2019 | - | 50 t. | 50 t. | 218 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
RAM BIOTECH ApS has published its annual report for 2022. Gross profit came to DKK -26,069, and the net result was DKK -28,654.
About RAM BIOTECH ApS
RAM BIOTECH ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2002. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named RAM BIOTECH ApS UNDER STIFTELSE. The management consists of Morten Steen Hanefeld Dziegiel. The board consists of Leif Kofoed Nielsen (chair), Morten Steen Hanefeld Dziegiel and Rasmus Lundquist. The company is owned by Leif Kofoed Nielsen, Morten Steen Hanefeld Dziegiel and Lundquist Medical ApS. The company has 1 employee (2004). In 2025, the company reported a gross profit of DKK -22,479 and a net result of DKK -22,479 compared with DKK -29,439 the year before. Equity in the 2025 report amounted to DKK 231,758.